The MAJESTY global phase 3 study evaluating obinutuzumab (Gazyva) in primary membranous nephropathy (PMN) demonstrated positive efficacy and safety outcomes. The trial successfully met its primary endpoint, with patients achieving…
USA: Researchers have found in a recent study that long-term opioid therapy (LTOT) is associated with a modestly increased risk of dental infections. The association, reported in PLOS One, suggests…
Turkey: The year 2025 marked a turning point in dyslipidaemia research, with major advances reshaping how lipid-related cardiovascular risk is understood and managed. In a viewpoint published in the European…
USA: A new study published in the MDPI journal Nutrients has raised concerns about the extent of ultra-processing in commercially available complementary foods for infants and toddlers in the United…
A 10-day dual regimen of vonoprazan and amoxicillin is noninferior to bismuth quadruple therapy for Helicobacter pylori eradication and demonstrates a superior safety profile, as reported in the Journal of…
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and top agency official Vinay Prasad
New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services (DGHS), Government of India, has issued a circular streamlining the testing of drugs for…
Signalling a zero-tolerance approach towards external pressure, the National Medical Commission has proposed amendments that would allow outright rejection of applications from medical colleges found attempting to influence the regulator…
Here are the top health stories for the day:Medical College Applications Could Be Rejected if NMC, MARB Face Pressure: NMCSignalling a zero-tolerance approach towards external pressure, the National Medical Commission…
Kottayam: A doctor from Kottayam acted swiftly to save a 50-year-old accident victim, giving him a second chance at life through timely cardiopulmonary resuscitation (CPR). The incident occurred on Tuesday…